Betaseron and Extavia (interferon-beta-1b) FDA-approved
- Details
- Category: Medications
- Written by R. Adam Quigley
- Hits: 2131
* subcutaneous (under skin) injection every other day
* interferon
* for relapsing-remitting, first symptom, and progressive-relapsing MS
* reduces relapse rate
* side effects: flu like symptoms, injection site reactions
* can cause depression
* approved in 1993



Ultrahigh-field strength, T1-weighted magnetization-prepared rapid acquisition and multiple gradient echoes (MPRAGE) is highly sensitive for detecting multiple sclerosis (MS) plaques within the white and gray brain parenchyma, according to a study published online Feb. 20 in Archives of Neurology, one of the JAMA/Archives...
Cannabis-based medicinal products, such as Sativex, could soon be available to sufferers of Multiple Sclerosis (MS) and other medical conditions on prescription.
One in a lakh Indians is thought to suffer from multiple sclerosis, a life-long disorder of the nervous system. Support groups are lobbying to bring the disease under the Disability Act, and are fighting for insurance cover.



